In this podcast episode, Ashwin Varma, a medical student with expertise in oncology and business development, offers a deep dive into Merck, a top pharmaceutical company. He explores the company's history, highlighting both its triumphs and hurdles, especially regarding its flagship drug, Keytruda. Varma sheds light on the intricate world of drug development, patent strategies, and how significant acquisitions shape Merck's future. The conversation underscores the critical role of innovation and strategic execution in a competitive market, wrapping up with key insights for investors looking to navigate the pharmaceutical landscape.
